In vivo combination treatment with a PARP inhibitor and radiation attenuated radiation‐induced glioma‐initiating cell enrichment and suppressed the tumor‐initiating CSC phenotype.234, 235. This evidence concerns the gene PARP1 and central nervous system cancer.